IL-2 in combination with IFN- α and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

Jens Atzpodien,H. Kirchner,H.-J. Illiger,Bernd Metzner,D. Ukena,H. Schott,P. J. Funke,Martin Gramatzki,S von Jürgenson,T. Wandert,T Patzelt,Martina Reitz

IL-2 in combination with IFN- α and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

2001

Jens Atzpodien
H. Kirchner
H.-J. Illiger
Bernd Metzner
D. Ukena
H. Schott
P. J. Funke
Martin Gramatzki
S von Jürgenson
T. Wandert
T Patzelt
Martina Reitz

IL-2 in combination with IFN- α and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

Keywords:

Randomized controlled trial
Immunology
Interferon alfa
Clinical trial
Carcinoma
Renal cell carcinoma
Antiestrogen
Medicine
Tamoxifen
Kidney
Hormonal therapy
Kidney disease
Regimen

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

129

Citations